Baseline results of a living systematic review for COVID-19 clinical trial registrations
Emilia Sitsofe Antonio & Sopuruchukwu Obiesie ( 2019-2020 cohort), Zineb Bentounsi & Vitalis Fambombi Feteh (2018-2019 cohort), Gerald Jamberi Makuka & Roland Ngu (2017-2018 cohort), Brittany J. Maguire , Alistair R.D. McLean, Sumayyah Rashan, Jayshree Bagaria, Matthew Brack, Fiona Caldwell, Verena Ilona Carrara , Barbara Wanjiru Citarella, Prabin Dahal, Marius H.B. Guérin, Kalynn Kennon , Kathinka Bilton Lahaut, Caitlin Richmond, Sauman Singh-Phulgenda , Samantha Strudwick, Carina S.B. Tyrrell, Austin Schwinn, David King , Paul N. Newton, Ric N. Price, Laura Merson, Kasia Stepniewska, Philippe J. Guérin
Since the coronavirus disease 2019 (COVID-19) outbreak was first reported in December 2019, many independent trials have been planned that aim to answer similar questions. Tools allowing researchers to review studies already underway can facilitate collaboration, cooperation and harmonisation.